-
CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) is still considered the gold standard in first-line therapy for aggressive non-Hodgkins lymphoma. Despite its place in clinical practice for 3 decades, there are issues that still are being evaluated.
-
The clinical value of single-agent trastuzumab in recurrent ovarian cancer is limited by the low frequency of HER2 overexpression and low rate of objective response among patients with HER2 overexpression.
-
Given that fewer than half of families approached about organ donation give consent, it is essential that hospitals and procurement coordinators examine how they approach families at such a crucial time, say officials with the United Network for Organ Sharing (UNOS).
-
UT Supreme Court upholds wrongful-life statute; Consumer group claims doctors strike unlawful; NEJM retracts study after authors point to forgery
-
-
Even as this country struggles with a shortage of organs from donors, some ethicists are beginning to question the morality of harvesting organs from the group that serves as their primary source patients who are brain dead but have functioning hearts, lungs, and circulatory systems.
-
As shortages continue, experts weigh alternatives. When a patient in Chicago nephrologist Paul W. Crawfords practice suddenly turned up with a new kidney after a trip to Mexico, the doctor didnt want to ask a lot of questions.
-
State health policy experts and pharmaceutical company officials are anxiously awaiting the U.S. Supreme Courts decision on a controversial Maine program designed to help residents unable to afford prescription drug coverage get lower-cost medications.
-
In another sign that a dangerous nosocomial pathogen is no longer confined to the hospital, a distinct strain of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) is emerging in Los Angeles, public health officials report.
-
In light of ongoing transmission of community-acquired methicillin-resistant Staphylococcus aureus (MRSA), the Los Angeles County Department of Health Ser-vices (LACDHS) issued an advisory to clinicians, summarized as follows:
